A detailed history of Hantz Financial Services, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 36,657 shares of CRL stock, worth $7.32 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
36,657
Previous 38,097 3.78%
Holding current value
$7.32 Million
Previous $7.87 Million 8.26%
% of portfolio
0.13%
Previous 0.15%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $270,662 - $353,217
-1,440 Reduced 3.78%
36,657 $7.22 Million
Q2 2024

Jul 30, 2024

BUY
$206.39 - $268.73 $7.86 Million - $10.2 Million
38,097 New
38,097 $7.87 Million
Q1 2024

Aug 06, 2024

SELL
$203.52 - $273.43 $445,098 - $597,991
-2,187 Reduced 5.22%
39,737 $10.8 Million
Q4 2023

Aug 06, 2024

SELL
$164.52 - $238.84 $527,780 - $766,198
-3,208 Reduced 7.11%
41,924 $9.91 Million
Q3 2023

Aug 06, 2024

BUY
$194.44 - $217.61 $6,805 - $7,616
35 Added 0.08%
45,132 $8.85 Million
Q2 2023

Aug 06, 2024

BUY
$183.71 - $210.25 $85,057 - $97,345
463 Added 1.04%
45,097 $9.48 Million
Q1 2023

Aug 06, 2024

BUY
$191.89 - $259.92 $256,173 - $346,993
1,335 Added 3.08%
44,634 $9.01 Million
Q4 2022

Aug 06, 2024

BUY
$197.11 - $250.07 $268,266 - $340,345
1,361 Added 3.25%
43,299 $9.44 Million
Q3 2022

Aug 06, 2024

SELL
$182.44 - $250.54 $584,172 - $802,229
-3,202 Reduced 7.09%
41,938 $8.25 Million
Q2 2022

Aug 06, 2024

BUY
$204.13 - $302.4 $243,527 - $360,763
1,193 Added 2.71%
45,140 $9.66 Million
Q1 2022

Aug 06, 2024

SELL
$255.51 - $362.11 $2.38 Million - $3.38 Million
-9,333 Reduced 17.52%
43,947 $12.5 Million
Q4 2021

Aug 06, 2024

BUY
$351.38 - $448.68 $1.16 Million - $1.49 Million
3,312 Added 6.63%
53,280 $20.1 Million
Q3 2021

Aug 06, 2024

BUY
$372.64 - $458.3 $2.61 Million - $3.21 Million
7,009 Added 16.32%
49,968 $20.6 Million
Q2 2021

Aug 06, 2024

BUY
$294.17 - $371.65 $780,727 - $986,359
2,654 Added 6.58%
42,959 $15.9 Million
Q1 2021

Aug 06, 2024

BUY
$249.67 - $299.48 $551,271 - $661,251
2,208 Added 5.8%
40,305 $11.7 Million
Q4 2020

Aug 06, 2024

BUY
$222.0 - $252.62 $30,414 - $34,608
137 Added 0.35%
38,890 $9.72 Million
Q3 2020

Aug 06, 2024

BUY
$175.56 - $226.45 $7,022 - $9,058
40 Added 0.1%
38,753 $8.78 Million
Q2 2020

Aug 06, 2024

BUY
$118.84 - $189.72 $106,480 - $169,989
896 Added 2.37%
38,713 $6.75 Million
Q1 2020

Aug 06, 2024

SELL
$98.9 - $178.34 $27,692 - $49,935
-280 Reduced 0.73%
37,817 $4.77 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.